Výsledky vyhledávání - "K, Rübsamen"

Comparison of the Antithrombotic Effect of PEG-Hirudin and Heparin in a Human Ex Vivo Model of Arterial Thrombosis

Autor: Kjell S. Sakariassen, Jean-Pierre Bossavy, Bernard Boneu, Yves Cadroy, K. Rübsamen, Claire Thalamas

Publikováno v: Arteriosclerosis, Thrombosis, and Vascular Biology. 19:1348-1353

Abstract —Polyethylene glycol (PEG)-hirudin is a derivative of hirudin with a long plasma half-life. We have compared the efficacy of PEG-hirudin with unfractionated heparin (UH) in preventing arterial thrombosis. Arterial thrombus formation was in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c7ae235eb5df733afc9228351d4d41
https://doi.org/10.1161/01.atv.19.5.1348

Zobrazit plný text záznamu

Inhibition of Arterial Thrombus Formation in Two Canine Models: Comparison of Ancrod, a Fibrinogen-Depleting Agent, the Thrombin-Inhibitor r-Hirudin, and the Glycoprotein IIb/IIIa-Receptor Antagonist Ro 43-8857

Autor: M Kirchengast, K Rübsamen, W Hornberger

Publikováno v: Thrombosis and Haemostasis. 74:1353-1360

SummaryInhibition of arterial thrombus formation by ancrod, a fibrinogen depleting agent isolated from a snake venom, r-hirudin, an inhibitor of thrombin-mediated fibrinogen cleavage, or the glycoprotein (GP)IIb/IIIa-receptor antagonist Ro 43-8857 in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::052d3e5b4008c0b860d752caa12c5dfa
https://doi.org/10.1055/s-0038-1649939

Zobrazit plný text záznamu

Reocclusion after thrombolysis

Autor: K Rübsamen, V Eschenfelder

Publikováno v: Blood Coagulation & Fibrinolysis. 2:97-100

The effect of recombinant hirudin (r-hir), unfractionated heparin (UFH) and acetylsalicylic acid (ASA) on the incidence of reocclusion after thrombolysis with plasminogen activator (rt-PA) was evaluated in anaesthetized rabbits. Formation of a platel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2281960c4991db7eead21c4d4802909f
https://doi.org/10.1097/00001721-199102000-00015

Zobrazit plný text záznamu

Effect of Recombinant Hirudin (LU 52369) on Reocclusion Rates after Thrombolysis in Rabbits

Autor: V. Eschenfelder, K. Rübsamen

Publikováno v: Pathophysiology of Haemostasis and Thrombosis. 21:93-98

The effect of recombinant hirudin (r-hirudin, LU 52369) and unfractionated heparin on recombinant tissue-type plasminogen activator (rt-PA; LU 50232) thrombolysis and reocclusion rates after successful thrombolysis was studied in a copper-coil-induce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf2b6afbc10b35cfaf66090274b1ebd2
https://doi.org/10.1159/000216268

Zobrazit plný text záznamu

Title Page / Table of Contents, Vol. 21, Supplement 1, 1991

Autor: Kevin A. Mitchell, M. Spannagl, Melitta Just, Mark D. Talbot, J. Bichler, Ron Almquist, Paul H. Johnson, Cris Olsen, M. Koehler, Robert B. Wallis, F. Doutremepuich, C. Vigneron, G. Pindur, M. Siebeck, F. Markwardt, E. Wenzel, Michael Wallock, F.A. Ofosu, Ch. Rauschenbach, J.W. Fenton, Jawed Fareed, K. Stocker, G. Nowak, H. Bichler, H. Fritz, Fritz Markwardt, B. Schulz, J. Walenga, Keith D. Butler, C.M. Kirchmaier, Richard C. Winant, Michael Koza, Dominique Tripier, Ping Sze, K. Narayanan, M.D. Liang, W. Schramm, Christopher M. Lees, K. Rübsamen, P. Zeiller, Jerome B. Lazar, H. Lill, William S. Fields, E. Glusa, M. Basic-Micic, C. Kirchmaier, John Ambler, Morris F. Tweed, V. Eschenfelder, A. Morin, Peter Underhill, E. Bucha, W. Raake, B. Fichtl, G.B. Villanueva, O.K. Bellinger, H. Elling, K. Krupinski, C. Doutremepuich, Debra Hoppensteadt, B. Braun, Dirk Seiffge, Mike Koza, M.C. Lalanne, H.K. Breddin, Debra Hudson, J. Stürzebecher, M. Heiden, J.M. Walenga, M. Marchand-Arvier, Roque Pifarre, Robin F. Peters, Jeanine M. Walenga, K. Breddin, R.J. Klauser, J.M. Maraganore, J. Fareed

Publikováno v: Pathophysiology of Haemostasis and Thrombosis. 21:I-IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::982bc78c67558a86681f7a8ed1feda41
https://doi.org/10.1159/000216257

Zobrazit plný text záznamu

Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity

Autor: C E, Dempfle, S, Argiriou, S, Alesci, K, Kucher, H, Müller-Peltzer, K, Rübsamen, D L, Heene

Publikováno v: Annals of the New York Academy of Sciences. 936

Ancrod is a purified fraction of venom from the Malayan pit viper Calloselasma rhodostoma, containing a serine protease that cleaves fibrinopeptides A from fibrinogen. We report on a study that involved intravenous and subcutaneous application of anc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::716d276666f3450fb2ec306e5646a5d4
https://pubmed.ncbi.nlm.nih.gov/11460476

Zobrazit plný text záznamu

Analysis of fibrin formation and proteolysis during intravenous administration of ancrod

Autor: C E, Dempfle, S, Argiriou, K, Kucher, H, Müller-Peltzer, K, Rübsamen, D L, Heene

Publikováno v: Blood. 96(8)

Ancrod is a purified fraction of venom from the Malayan pit viper, Calloselasma rhodostoma, currently under investigation for treatment of acute ischemic stroke. Treatment with ancrod leads to fibrinogen depletion. The present study investigated the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::49d62cb2511fdcf3111bfa03789e6cfe
https://pubmed.ncbi.nlm.nih.gov/11023513

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání